The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 10, 2018
Filed:
Jun. 27, 2016
Applicant:
Lutonix, Inc., New Hope, MN (US);
Inventor:
Lixiao Wang, Medina, MN (US);
Assignee:
Lutonix, Inc., New Hope, MN (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61F 13/00 (2006.01); A61M 31/00 (2006.01); A61K 31/436 (2006.01); A61K 31/337 (2006.01); A61L 29/16 (2006.01); A61L 31/16 (2006.01); A61L 29/08 (2006.01); A61M 25/10 (2013.01); A61F 2/82 (2013.01); A61K 9/00 (2006.01); A61M 16/04 (2006.01);
U.S. Cl.
CPC ...
A61K 31/436 (2013.01); A61F 2/82 (2013.01); A61K 9/0019 (2013.01); A61K 31/337 (2013.01); A61L 29/08 (2013.01); A61L 29/085 (2013.01); A61L 29/16 (2013.01); A61L 31/16 (2013.01); A61M 16/0434 (2013.01); A61M 25/10 (2013.01); A61F 2250/0067 (2013.01); A61K 9/0073 (2013.01); A61L 2300/41 (2013.01); A61L 2300/416 (2013.01); A61L 2420/02 (2013.01); A61L 2420/06 (2013.01); A61M 2025/105 (2013.01); A61M 2210/0618 (2013.01);
Abstract
Embodiments of the present invention provide a method for treatment of respiratory disorders such as asthma, chronic obstructive pulmonary disease, and chronic sinusitis, including cystic fibrosis, interstitial fibrosis, chronic bronchitis, emphysema, bronchopulmonary dysplasia and neoplasia. The method involves administration, preferably oral, nasal or pulmonary administration, of anti-inflammatory and anti-proliferative drugs (rapamycin or paclitaxel and their analogs) and an additive.